Evidence map›Paper›PMID 41096670›Full record

ArticleInternational journal of molecular sciences2025

Selective Degradation and Inhibition of SARS-CoV-2 3CL

Hyun Lee, Yunjeong Hwang, Elizabeth J Mulder, Yuri Song, Calista Choi, Lijun Rong, Dimitri T Azar, Kyu-Yeon Han

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hyun LeeDepartment of Pharmaceutical Science, College of Pharmacy & Biophysics Core, the Research Resource Center, University of Illinois Chicago, Chicago, IL 60607, USA.ORCID 0000-0003-2570-8120
Yunjeong HwangDepartment of Ophthalmology and Visual Sciences, Illinois Eye and Ear Infirmary, College of Medicine, University of Illinois Chicago, Chicago, IL 60612, USA.
Elizabeth J MulderBiophysics Core, the Research Resource Center, University of Illinois Chicago, Chicago, IL 60607, USA.ORCID 0000-0002-8613-2340
Yuri SongBiophysics Core, the Research Resource Center, University of Illinois Chicago, Chicago, IL 60607, USA.
Calista ChoiBiophysics Core, the Research Resource Center, University of Illinois Chicago, Chicago, IL 60607, USA.
Lijun RongDepartment of Microbiology and Immunology, College of Medicine, University of Illinois Chicago, Chicago, IL 60612, USA.
Dimitri T AzarDepartment of Ophthalmology and Visual Sciences, Illinois Eye and Ear Infirmary, College of Medicine, University of Illinois Chicago, Chicago, IL 60612, USA.
Kyu-Yeon HanDepartment of Ophthalmology and Visual Sciences, Illinois Eye and Ear Infirmary, College of Medicine, University of Illinois Chicago, Chicago, IL 60612, USA.

Funding

Translational Core for Therapeutic and Diagnostic DevelopmentP30EY001792 · NEI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI AAKALU, VINAY · 1985 to 2025
$14.8M
Identification of a new role of membrane‐type 1 matrix metalloproteinases in corneal neovascularizationR01EY033758 · NEI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI Kyuyeon Han · 2023 to 2026
$1.6M
Development of MMP14-laden exosomes as a novel anti-SARS-CoV-2 therapyR21AI168744 · NIAID · UNIVERSITY OF ILLINOIS AT CHICAGO · PI HAN, KYUYEON · 2023 to 2024
$440k
NEI NIH HHS P30 EY001792NEI NIH HHS R01 EY033758NIAID NIH HHS R21 AI168744NIH HHS 1R01EY010101-02
6 · The paper itself

Abstract

Novel therapies to treat infection by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of respiratory coronavirus disease 2019 (COVID-19), would be of great clinical value to combat the current and future pandemics. Two viral proteases, papain-like protease (PL

Indexed as

Coronavirus 3C ProteasesCysteine EndopeptidasesMatrix Metalloproteinase 14Viral Nonstructural ProteinsAntiviral AgentsCOVID-19COVID-19 Drug TreatmentHumansPandemicsProteolysisSARS-CoV-23C-like proteinase, SARS-CoV-2Antiviral AgentsCoronavirus 3C ProteasesCysteine EndopeptidasesMatrix Metalloproteinase 14MMP14 protein, humanViral Nonstructural Proteins3CLproenzyme inhibitionMMP14SARS-CoV-2

Identifiers

PMID41096670
PMCPMC12524713

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.